PubMed:10080908
Annnotations
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 235-256 | protein | denotes | transcription factors |
| T2 | 257-261 | protein | denotes | PU.1 |
| T3 | 266-276 | protein | denotes | C/EBPalpha |
| T4 | 333-343 | cell_type | denotes | stem cells |
| T5 | 347-356 | cell_type | denotes | monocytes |
| T6 | 389-393 | protein | denotes | PU.1 |
| T7 | 420-473 | protein | denotes | macrophage colony-stimulating factor (M-CSF) receptor |
| T8 | 497-506 | cell_type | denotes | monocytes |
| T9 | 516-526 | protein | denotes | C/EBPalpha |
| T10 | 559-613 | protein | denotes | granulocyte colony-stimulating factor (G-CSF) receptor |
| T11 | 634-646 | cell_type | denotes | granulocytes |
| T12 | 690-702 | protein | denotes | oncoproteins |
| T13 | 711-719 | protein | denotes | AML1/ETO |
| T14 | 721-733 | protein | denotes | PML/RARalpha |
| T15 | 738-751 | protein | denotes | activated Ras |
| T16 | 821-829 | protein | denotes | AML1/ETO |
| T17 | 846-866 | protein | denotes | transcription factor |
| T18 | 867-877 | protein | denotes | C/EBPalpha |
| T19 | 887-897 | protein | denotes | C/EBPalpha |
| T20 | 972-980 | protein | denotes | AML1/ETO |
| T21 | 1009-1029 | protein | denotes | transcription factor |
| T22 | 1030-1034 | protein | denotes | AML1 |
| T23 | 1066-1089 | DNA | denotes | M-CSF receptor promoter |
| T24 | 1114-1141 | protein | denotes | PML/RARalpha fusion protein |
| T25 | 1194-1249 | protein | denotes | nuclear corepressor (N-CoR) histone deacetylase complex |
| T26 | 1289-1296 | protein | denotes | histone |
| T27 | 1326-1335 | DNA | denotes | chromatin |
| T28 | 1464-1476 | protein | denotes | oncoproteins |
| T29 | 1523-1544 | protein | denotes | transcription factors |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 91-119 | NP | denotes | Acute myeloid leukemia (AML) |
| C2 | 171-174 | NP | denotes | AML |
| C3 | 206-229 | NP | denotes | myeloid differentiation |
| C4 | 347-356 | NP | denotes | monocytes |
| C5 | 497-506 | NP | denotes | monocytes |
| C6 | 516-526 | NP | denotes | C/EBPalpha |
| C7 | 651-654 | NP | denotes | AML |
| C10 | 711-719 | NP | denotes | AML1/ETO |
| C11 | 721-733 | NP | denotes | PML/RARalpha |
| C9 | 690-751 | NP | denotes | oncoproteins such as AML1/ETO, PML/RARalpha, or activated Ras |
| C12 | 753-758 | NP | denotes | which |
| C8 | 690-813 | NP | denotes | oncoproteins such as AML1/ETO, PML/RARalpha, or activated Ras, which can deregulate genes important for normal myelopoiesis |
| C13 | 821-829 | NP | denotes | AML1/ETO |
| C14 | 842-877 | NP | denotes | the transcription factor C/EBPalpha |
| C15 | 972-980 | NP | denotes | AML1/ETO |
| C16 | 1110-1141 | NP | denotes | the PML/RARalpha fusion protein |
| C17 | 1149-1260 | NP | denotes | transcriptional repression by recruiting the nuclear corepressor (N-CoR) histone deacetylase complex to the DNA |
| C18 | 1262-1267 | NP | denotes | which |
| C19 | 1432-1455 | NP | denotes | myeloid differentiation |
| C20 | 1464-1476 | NP | denotes | oncoproteins |
| C21 | 1489-1492 | NP | denotes | AML |
| C22 | 1523-1544 | NP | denotes | transcription factors |
| C23 | 1545-1549 | NP | denotes | that |
| R1 | C2 | C1 | coref-ident | AML,Acute myeloid leukemia (AML) |
| R2 | C5 | C4 | coref-ident | monocytes,monocytes |
| R3 | C7 | C2 | coref-ident | AML,AML |
| R4 | C12 | C9 | coref-relat | which,"oncoproteins such as AML1/ETO, PML/RARalpha, or activated Ras" |
| R5 | C13 | C10 | coref-ident | AML1/ETO,AML1/ETO |
| R6 | C14 | C6 | coref-ident | the transcription factor C/EBPalpha,C/EBPalpha |
| R7 | C15 | C13 | coref-ident | AML1/ETO,AML1/ETO |
| R8 | C16 | C11 | coref-ident | the PML/RARalpha fusion protein,PML/RARalpha |
| R9 | C18 | C17 | coref-relat | which,transcriptional repression by recruiting the nuclear corepressor (N-CoR) histone deacetylase complex to the DNA |
| R10 | C19 | C3 | coref-ident | myeloid differentiation,myeloid differentiation |
| R11 | C20 | C8 | coref-ident | oncoproteins,"oncoproteins such as AML1/ETO, PML/RARalpha, or activated Ras, which can deregulate genes important for normal myelopoiesis" |
| R12 | C21 | C7 | coref-ident | AML,AML |
| R13 | C23 | C22 | coref-relat | that,transcription factors |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-90 | Sentence | denotes | Analysis of the modulation of transcriptional activity in myelopoiesis and leukemogenesis. |
| S2 | 91-170 | Sentence | denotes | Acute myeloid leukemia (AML) is still associated with a mortality of 60 to 80%. |
| S3 | 171-230 | Sentence | denotes | AML is characterized by a block in myeloid differentiation. |
| S4 | 231-373 | Sentence | denotes | The transcription factors PU.1 and C/EBPalpha are responsible for normal myeloid differentiation from stem cells to monocytes or granulocytes. |
| S5 | 374-647 | Sentence | denotes | In particular, PU.1 induces expression of the macrophage colony-stimulating factor (M-CSF) receptor and the development of monocytes, whereas C/EBPalpha increases the expression of the granulocyte colony-stimulating factor (G-CSF) receptor and leads to mature granulocytes. |
| S6 | 648-814 | Sentence | denotes | In AML, chromosomal aberrations result in oncoproteins such as AML1/ETO, PML/RARalpha, or activated Ras, which can deregulate genes important for normal myelopoiesis. |
| S7 | 815-962 | Sentence | denotes | Thus, AML1/ETO can bind to the transcription factor C/EBPalpha, inhibit C/EBPalpha-dependent transcription, and block granulocytic differentiation. |
| S8 | 963-1090 | Sentence | denotes | However, AML1/ETO can also synergize with the transcription factor AML1 to enhance the activity of the M-CSF receptor promoter. |
| S9 | 1091-1349 | Sentence | denotes | On the other hand, the PML/RARalpha fusion protein causes transcriptional repression by recruiting the nuclear corepressor (N-CoR) histone deacetylase complex to the DNA, which results in decreased histone acetylation and a repressive chromatin organization. |
| S10 | 1350-1593 | Sentence | denotes | Here we describe methods to investigate whether and how signaling agonists induce myeloid differentiation and how oncoproteins might cause AML by modulating the activity of transcription factors that are pivotal for normal myeloid development. |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 30-54 | other_name | denotes | transcriptional activity |
| T2 | 58-70 | other_name | denotes | myelopoiesis |
| T3 | 75-89 | other_name | denotes | leukemogenesis |
| T4 | 91-113 | other_name | denotes | Acute myeloid leukemia |
| T5 | 115-118 | other_name | denotes | AML |
| T6 | 171-174 | other_name | denotes | AML |
| T7 | 206-229 | other_name | denotes | myeloid differentiation |
| T8 | 235-256 | protein_family_or_group | denotes | transcription factors |
| T9 | 257-261 | protein_molecule | denotes | PU.1 |
| T10 | 266-276 | protein_molecule | denotes | C/EBPalpha |
| T11 | 304-327 | other_name | denotes | myeloid differentiation |
| T12 | 333-343 | cell_type | denotes | stem cells |
| T13 | 347-356 | cell_type | denotes | monocytes |
| T14 | 389-393 | protein_molecule | denotes | PU.1 |
| T15 | 420-473 | protein_molecule | denotes | macrophage colony-stimulating factor (M-CSF) receptor |
| T16 | 497-506 | cell_type | denotes | monocytes |
| T17 | 516-526 | protein_molecule | denotes | C/EBPalpha |
| T18 | 559-613 | protein_molecule | denotes | granulocyte colony-stimulating factor (G-CSF) receptor |
| T19 | 634-646 | cell_type | denotes | granulocytes |
| T20 | 651-654 | other_name | denotes | AML |
| T21 | 656-679 | other_name | denotes | chromosomal aberrations |
| T22 | 690-702 | protein_family_or_group | denotes | oncoproteins |
| T23 | 711-719 | protein_molecule | denotes | AML1/ETO |
| T24 | 721-733 | protein_molecule | denotes | PML/RARalpha |
| T25 | 738-751 | protein_molecule | denotes | activated Ras |
| T26 | 801-813 | other_name | denotes | myelopoiesis |
| T27 | 821-829 | protein_molecule | denotes | AML1/ETO |
| T28 | 846-866 | protein_family_or_group | denotes | transcription factor |
| T29 | 867-877 | protein_molecule | denotes | C/EBPalpha |
| T30 | 887-897 | protein_molecule | denotes | C/EBPalpha |
| T31 | 972-980 | protein_molecule | denotes | AML1/ETO |
| T32 | 1009-1029 | protein_family_or_group | denotes | transcription factor |
| T33 | 1030-1034 | protein_molecule | denotes | AML1 |
| T34 | 1066-1089 | DNA_domain_or_region | denotes | M-CSF receptor promoter |
| T35 | 1114-1126 | protein_molecule | denotes | PML/RARalpha |
| T36 | 1149-1175 | other_name | denotes | transcriptional repression |
| T37 | 1194-1249 | protein_complex | denotes | nuclear corepressor (N-CoR) histone deacetylase complex |
| T38 | 1289-1296 | protein_family_or_group | denotes | histone |
| T39 | 1326-1335 | DNA_family_or_group | denotes | chromatin |
| T40 | 1406-1424 | other_name | denotes | signaling agonists |
| T41 | 1432-1455 | other_name | denotes | myeloid differentiation |
| T42 | 1464-1476 | protein_family_or_group | denotes | oncoproteins |
| T43 | 1489-1492 | other_name | denotes | AML |
| T44 | 1523-1544 | protein_family_or_group | denotes | transcription factors |
| T45 | 1566-1592 | other_name | denotes | normal myeloid development |
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 91-113 | HP_0004808 | denotes | Acute myeloid leukemia |
| T2 | 97-113 | HP_0012324 | denotes | myeloid leukemia |
| T3 | 105-113 | HP_0001909 | denotes | leukemia |